Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
Status:
Recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
This phase II/III trial studies how well methylphenidate and exercise work in reducing
cancer-related fatigue in patients with prostate cancer. Methylphenidate is a type of central
nervous system stimulant that can improve cognitive ability, mainly in memory and cognitive
function. Exercise can improve mood and the physical aspects of cancer-related fatigue.
Giving methylphenidate in combination with exercise may work better in reducing
cancer-related fatigue in patients with prostate cancer.